28m
Hosted on MSNHologic Wins Key Approvals Post Q1 Results: Buy or Hold HOLX Stock?Hologic HOLX earned two key regulatory approvals. The company’s Affirm Contrast Biopsy software has earned the CE Mark, having previously been cleared by the FDA in October 2020. Meanwhile, the Aptima ...
44mon MSN
Sen. Roger Marshall (R-Kan.) introduced a bill Wednesday to prohibit federal grants going toward all “dangerous” ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results